Prof. György M. Keserű

Prof. György M. Keserű obtained his Ph.D. at Budapest, Hungary and joined Sanofi-Aventis CHINOIN heading a chemistry research lab. He moved to Gedeon Richter in 1999 as the Head of Computer-aided Drug Discovery. He earned D.Sc. from the Hungarian Academy of Science in 2003 and he was invited for a research professorship at the Budapest University of Technology and Economics. Since 2007 he was appointed as the Head of Discovery Chemistry at Gedeon Richter. He contributed to the discovery of the antipsychotic VRAYLAR™ (RGH-188, cariprazine) that received FDA approval in 2015. From January 2013 he serves as the general director of the Research Center for Natural Sciences at the Hungarian Academy of Sciences. His research interests include medicinal chemistry, drug design, and in silico ADME. He has published over 170 papers and more than 10 books and book chapters. In 2014 he received the Overton and Meyer Award with György G. Ferenczy from the European Federation of Medicinal Chemistry for their contribution to new strategies of medicinal chemistry optimizations.